BEA-28
Asset
Targeted protein degradation of TEAD transcription factors
- Stage
- Preclinical
- Modality
- Small molecule
- Target
- TEAD1
- 2
- Indications
- 0
- Trials
- 1
- Developer
Indications
2Biomarker-selected cancers
Preclinical, prnewswire.com, 6 Oct 2026
Cancer
Preclinical, prnewswire.com, 6 Oct 2026
In the full profile
- Targets and what it contains4
- Owner and partners1
- Evidence for its targets3
- Competitors12
Every asset’s record: target, stage, trials and the evidence behind it.